Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1‐year treat‐to‐target trial
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The long‐term safety and tolerability of insulin degludec ( IDeg ) was compared with that of insulin detemir ( IDet ), as basal treatment in participants with type 1 diabetes mellitus ( T1DM ). In the present multinational, 26‐week core + 26‐week extension, controlled, open‐label, parallel‐group trial, adults with T1DM were randomized to IDeg or IDet as basal insulin treatment combined with meal‐time bolus insulin aspart. IDeg was administered once daily, whilst IDet was administered once or twice daily depending on patients' glycaemic control. After 1 year, IDeg provided a 33% lower rate of nocturnal hypoglycaemia compared with IDet : estimated rate ratio ( IDeg : IDet ) 0.67 [95% confidence interval ( CI ) 0.51; 0.88]; p < 0.05. IDeg improved glycated haemoglobin after 1 year of treatment, similarly to IDet , but IDeg also provided a significantly greater reduction in fasting plasma glucose compared with IDet : estimated difference ( IDeg − IDet ) −1.11 (95% CI −1.83; −0.40) mmol/l; p < 0.05. The present study confirmed the long‐term safety and tolerability profile of IDeg in patients with T1DM . IDeg provided a lower risk of nocturnal confirmed hypoglycaemia than IDet .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
Jonassen, I., Havelund, S., Hoeg-Jensen, T., Steensgaard, D. B., Wahlund, P.-O., & Ribel, U. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0739-z · Cited by 448
Heise, T., Hermanski, L., Nosek, L., Feldman, A., Rasmussen, S., & Haahr, H. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01627.x · Cited by 397
Cited by
Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
Janež, A., Guja, C., Mitrakou, A., Lalic, N., Tankova, T., Czupryniak, L., Tabák, A. G., Prazny, M., Martinka, E., & Smircic-Duvnjak, L. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00743-7 · Cited by 177
(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
Hemmingsen, B., Metzendorf, M.-I., & Richter, B. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013498.pub2 · Cited by 37
Fadini, G. P., Feher, M., Hansen, T. K., de Valk, H. W., Koefoed, M. M., Wolden, M., Zimmermann, E., & Jendle, J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01021 · Cited by 27
Thalange, N., Gundgaard, J., Parekh, W., & Tutkunkardas, D. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000664 · Cited by 7
Metadata
- Authors
- Davies, M., Sasaki, T., Gross, J. L., Bantwal, G., Ono, Y., Nishida, T., Tojjar, D., & Seino, H.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2015-10-19
- Volume
- 18
- Issue
- 1
- Pages
- 96-99
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2108937883
- Cited by
- 33
- References
- 2
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.